INGN Q2 2021 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$102M+41.7% YoY

Gross Profit

$50M49.6% margin

Operating Income

$12M11.5% margin

Net Income

$5M5.0% margin

EPS (Diluted)

$0.22

QoQ Revenue Growth

+16.8%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$498M

Total Liabilities

$127M

Stockholders' Equity

$371M

Cash & Equivalents

$239M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$102M	$72M	+41.7%
Gross Profit	$50M	$33M	+53.7%
Operating Income	$12M	-$2M	+596.4%
Net Income	$5M	$3M	+97.8%

Geographic Segments

UNITED STATES

$80M79%

Non Us

$22M21%